As for immunohistochemistry, EMA expression was respectively detected positive in 96% (216/225) of all meningiomas, 98% (98/100) of grade I meningiomas, 96% (96/100) of grade II meningiomas, and 88% (22/25) of grade III meningiomas. The gene discussed is MUC1; the disease is meningioma.